Exercise-uncovered pulmonary arterial hypertension and pharmacologic therapy: Clinical benefits

Journal of Heart and Lung Transplantation

Volumn 29, Issue 2, 2010, Pages 228-229

  Park, Myung H ^a   Ramani, Gautam V ^a   Kop, Willem J ^a   Uber, Patricia A ^a   Mehra, Mandeep R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BOSENTAN; CARBON MONOXIDE; SILDENAFIL;

ADULT; AGED; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART CATHETERIZATION; HUMAN; LETTER; LUNG DIFFUSION CAPACITY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRURITUS; PULMONARY HYPERTENSION; SIDE EFFECT; WALKING;

ADULT; AGED; EXERCISE; FEMALE; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED;

EID: 74849130483     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.10.010     Document Type: Letter

References (5)

1. Badesch D.B., Champion H.C., Sanchez M.A., et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54 suppl (2009) S55-S66
2. Steen V., Chou M., Shanmugam V., et al. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 134 (2008) 146-151
3. Tolle J.J., Waxman A.B., Van Horn T.L., et al. Exercise-induced pulmonary arterial hypertension. Circulation 118 (2008) 1-7
4. Galie N., Rubin L.J., Hoeper M.M., et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomized controlled trial. Lancet 371 (2008) 2093-2100
5. McLaughlin V.V., Archer S.L., Badesch D.B., et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. J Am Coll Cardiol 53 (2009) 1573-1619